Stay updated on FIREFISH: Risdiplam in Type1 SMA Infants Clinical Trial

Sign up to get notified when there's something new on the FIREFISH: Risdiplam in Type1 SMA Infants Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the FIREFISH: Risdiplam in Type1 SMA Infants Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The screenshot shows minor UI and layout adjustments on the Study Details page, with no changes to the study data, eligibility criteria, or listed locations (To avoid being alerted by small changes, set an alert condition by clicking below).
    Difference
    0.3%
    Check dated 2025-11-03T11:45:37.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    33 days ago
    Change Detected
    Summary
    Updated page to version v3.2.0, added operating-status notice and a new resource on Spinal muscular atrophy; removed the old revision v3.1.0 reference.
    Difference
    2%
    Check dated 2025-10-05T17:19:58.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no substantive content changes detected.
    Difference
    0.0%
    Check dated 2025-09-28T10:09:41.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    The page updates the revision from v3.0.1 to v3.0.2 and removes the Back to Top element. This does not affect core content or other critical information.
    Difference
    0.1%
    Check dated 2025-09-14T00:21:56.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.
    Difference
    0.1%
    Check dated 2025-09-06T21:11:56.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of multiple facility locations across various countries, such as Belgium, Brazil, Italy, Japan, Poland, Russia, Spain, Turkey, and Ukraine. Additionally, a new reference to a pharmacokinetic study has been included, while previous location entries have been removed.
    Difference
    3%
    Check dated 2025-08-30T15:41:02.000Z thumbnail image

Stay in the know with updates to FIREFISH: Risdiplam in Type1 SMA Infants Clinical Trial

Enter your email address, and we'll notify you when there's something new on the FIREFISH: Risdiplam in Type1 SMA Infants Clinical Trial page.